The Effects Of Chromium Supplementation On Endocrine Profiles, Biomarkers Of Inflammation, And Oxidative Stress In Women With Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
|Values||20% prevalence in placebo group vs. 3.3% in chromium group after 8 weeks.|
|Trial Design||Randomized trial|
|Trial Length||1-6 months|
|Number of Subjects||60|
|Age Range||18-29, 30-44|
60 woman with PCOS were given either placebo or 200 µg chromium picolinate for 8 weeks. Chromium reduced acne, hirsutism, and C-reactive protein and improved plasma total antioxidant capacity but no change in reproductive hormones (FSH, LH, prolactin, and free testosterone).